Le Lézard
Classified in: Health, Science and technology
Subject: Photo/Multimedia

Statement from Biocom California and MassBio on America's Biotechnology Leadership and National Security


The following statement can be attributed to Joe Panetta, Biocom California's president and CEO, and Kendalle Burlin O'Connell, Massachusetts Biotechnology Council's (MassBio) CEO and president.

"We strongly support efforts to continue American leadership in the biotechnology sector. We must look at ways to expand domestic capabilities for pharmaceutical research and manufacturing to ensure patient access to innovative medicines often developed by smaller companies that are most reliant on federal grants or contracts. We know that a strong American biotechnology sector is a key national security asset and will continue to work with policymakers and industry leaders to accomplish our shared goals of promoting access to innovation for American patients while protecting our national security."

About Biocom California

Biocom California is the leader and advocate for California's life science sector. We work on behalf of more than 1,700 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs.

Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C. and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers.

For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and X.

About MassBio

MassBio's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. MassBio represents the premier global life sciences and healthcare hub, with 1,600+ members dedicated to preventing, treating, and curing diseases through transformative science and technology that brings value and hope to patients. Founded in 1985, MassBio works to advance policy and promote education, while providing member programs, events, industry thought leadership, and services for the #1 life sciences cluster in the world.

For more information on MassBio, please visit our website at www.massbio.org. Connect with us on LinkedIn, X, Instagram, and MB Vision, our online video library.


These press releases may also interest you

at 18:05
ARHT Media Inc. ("ARHT" or the "Company") , announced today that it will be delayed in filing its financial statements, the accompanying management's discussion and analysis, and related documents with respect to the annual filings for the year...

at 18:00
Energizer Holdings, Inc. announced that its Board of Directors declared a dividend on its common stock of $0.30 per share. The dividend will be payable on June 12, 2024 to shareholders of record as of the close of business on May 22, 2024....

at 17:55
Sinovac Biotech Ltd. ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, has filed its 2023 annual report on Form 20-F with the U.S. Securities and Exchange Commission for the year ended December 31, 2023. The...

at 17:42
The Tech, the world-renowned science, technology, and education center in the heart of Silicon Valley, announces the results of the Final Showcase of 37th Annual Tech Challenge, which took place on April 27-28 in downtown San Jose. Presented by...

at 17:31
DelveInsight's Malignant Ascites Market Insights report includes a comprehensive understanding of current treatment practices, malignant ascites emerging...

at 17:05
Paycom Software, Inc. ("Paycom") , a leading provider of comprehensive, cloud-based human capital management software, announced today that its Board of Directors declared a cash dividend in the amount of $0.375 per share of common stock, to be paid...



News published on and distributed by: